Canada’s Drug Agency recommends against public drug plans covering new breakthrough Alzheimer’s drug Lecanemab. Vassy Kapelos speaks with Dr. Sharon Cohen, Medical Director of the Toronto Memory Program amd specialist in Alzheimer’s diagnosis and treatment.

Listen to The Vassy Kapelos podcast on the iHeart radio app, Apple Podcasts, Spotify, or wherever you listen to your podcasts. Follow us on Twitter at @VassKapelosShow and on Instagram at @VassyKapelosShow.

<p>Canada&rsquo;s Drug Agency recommends against public drug plans covering new breakthrough Alzheimer&rsquo;s drug Lecanemab. Vassy Kapelos speaks with Dr. Sharon Cohen, Medical Director of the Toronto Memory Program amd specialist in Alzheimer&rsquo;s diagnosis and treatment.</p>
<p>Listen to The Vassy Kapelos podcast on the iHeart radio app, Apple Podcasts, Spotify, or wherever you listen to your podcasts. Follow us on Twitter at @VassKapelosShow and on Instagram at @VassyKapelosShow.</p>